Rösch AG Medizintechnik
Rösch AG Medizintechnik english

RÖSCH AG closes contract with Chinese distribution company Wearmax Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– RÖSCH AG closes contract with Chinese distribution company Wearmax Holdings, Ltd. The Berlin based medical device company RÖSCH AG Medizintechnik herewith announces the signing of a distribution agreement for INJEX with Wearmax Holding Ltd. for the territory of China. Wearmax is headquartered in Hong Kong and in addition is present with several offices and joint ventures in China. In 2001 Wearmax realized a turnover of around 25 million Euro* mainly generated by marketing and selling of pharmaceuticals, diagnostics, medical devices and technical services. Wearmax has a high reputation in the health care market in China with strong links to hospitals as well as to the ambulatory field which is in addition highlighted by the fact that Wearmax is representative agent of well known international companies like Robert Bosch GmbH. Both companies believe that the INJEX-system of RÖSCH has interesting perspectives in China, taking into consideration the strongly growing number of patients with type II diabetes. RÖSCH AG has specialised in developing and marketing needle free application technology and with its innovative INJEX-system ‘Syringe without a needle’ already entered several international markets. Further information under: RÖSCH AG Medizintechnik Investor Relations Buckower Damm 114 12349 Berlin Tel: +49-30-667915-930 Fax: +49-30-667915-66 e-mail: scherfenberg@roesch-ag.de Web: http://www.roesch-ag.de end of message, (c)DGAP 04.04.2002